Form D · Other Health Care

Luna Pharmaceuticals, Inc.

Providence, RI · CIK 0001688483

Offering snapshot reported Feb 9, 2021 · SEC filing

Reported sold
Yet to sell
Offering amount: $5.9M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 9, 2021InitialYet to sellNo comparison0SEC filing
Dec 26, 2019Initial$2,264,176No comparison10SEC filing
Jan 31, 2019Amendment$516,758$306,758vs Mar 15, 201821SEC filing
Mar 15, 2018Initial$210,000No comparison8SEC filing
Nov 8, 2016Initial$1,823,637No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-388856

Source: Form D, filed Feb 9, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dan Aziz Director, Executive
Robert D. Aziz Director, Executive
Charlie Baynes Reid Director
Arlene Dickinson Director
Peter Finn Executive
Richard Katzman Director
Mark Lehrol Director
Mark Lerohl Director
Anthony Longo Director
Raymond Mathieu Director, Executive
Ray Mathieu Director
Kevin Murphy Director
Amy Wolf Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
244 Weybosset Street
Providence, RI, 02903